Business
Press Release Aug 20 2025
Lupin Limited has informed the Exchange regarding a press release dated August 20, 2025, titled "Lupin Launches Bosentan Tablets for Oral Suspension in the United Stateswith 180-Day Exclusivity".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated August 20, 2025, titled \"Lupin Launches Bosentan Tablets for Oral Suspension in the United Stateswith 180-Day Exclusivity\". View Attachment","length":360,"tagName":"div"}]